SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cash Cat

Cash Cat is drawing attention after a volatile rally and sharp pullbacks, with traders debating whether rebounds can hold or are another pump-and-dump cycle. Bulls point to speculative Robinhood-chain utility, token burns and short-squeeze potential, while skeptics emphasize the coins difficulty holding gains.

Tidal Trust II - Defiance Daily Target 2x Long MSTR ETF

Defiance Daily Target 2x Long MSTR ETF

Traders are focused on MSTXs leveraged exposure to Strategy (MSTR) and Bitcoin, with bullish posts tying hopes for further gains to a BTC/MSTR rebound and potential short squeeze. Others warn that leverage and volatility can amplify losses and erode value over time.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax shares are drawing attention after moving above key technical levels, with traders attributing the rally partly to options activity and a possible gamma squeeze around the $15 strike; that explanation is speculative, and some caution the move lacks fresh company news. The broader bullish case centers on expected growth from co-packaged optics, automotive chips and AI-related products, though near-term direction remains debated.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WRD is drawing attention amid a steep slide to fresh lows, as traders question the companys ability to turn fleet expansion and ADAS deployments into collected revenue while controlling losses and cash burn. Some investors remain optimistic about the growth pipeline, but the dominant discussion is frustration over the stocks performance and doubts about managements execution and communication.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

Midnights reported mainnet launch, with Google Cloud and Vodafone among its validators, is drawing attention alongside discussion of a Coinbase listing. Reactions are mixed: some see the network milestones as support for Midnights privacy-focused vision, while others cite token unlocks and airdrop selling, weak demand, and concerns about centralization as headwinds.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

FETs rebound is drawing attention, with traders tying the move to renewed interest in AI and autonomous-agent tokens and discussion of Fetchs ASI ecosystem and product updates. Bullish traders see a potential breakout, while skeptics point to FETs past underperformance and warn that follow-through may depend on Bitcoin and broader crypto-market conditions.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick is drawing attention as traders position for a broader gold and commodities cycle, citing concerns about debt, inflation and currency weakness alongside miners cash generation. The bullish outlook is tempered by debate over Barricks execution and the timing of its planned North American IPO, as well as short-term pullbacks in gold-mining shares.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp, high-volume breakout with no confirmed company announcement is driving attention, with traders attributing the move to possible institutional buying and short covering. The community is also speculating that Michael Caputos appointment to the Presidents Cancer Panel and his online engagement around Anktiva could bring attention or access for ImmunityBio, though others note that no concrete catalyst has been disclosed.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

Attention centers on renewed optimism about XRP ETF demand and potential approvals, with traders citing sustained fund inflows and institutional interest. Sentiment is mixed: some expect the ETF interest to support XRP, while others point to muted price action despite a steady stream of catalysts.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

The DOJs closure of its antitrust review of Transoceans Valaris acquisition is the main focus, with traders viewing it as a major hurdle cleared while noting the deal still awaits other closing conditions. Optimists point to potential scale and synergies, while skeptics remain concerned about share dilution, persistent short interest, and RIGs muted price response.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AI, Cancer Vaccines, and Next-Gen Medicine 

Could cancer vaccines and AI drive the next wave of healthcare innovation?

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Merck-Moderna's melanoma vaccine success could boost immunotherapy growth, putting healthcare ETFs in the spotlight.

Biotech ETF (CANC) Hits New 52-Week High

CANC hits a 52-week high as strong oncology developments and positive momentum fuel the biotech ETF's rally.

Wall Street Believes Celcuity Could Become An Acquisition Target – Why This Analyst Raised Their Price Target By A Whopping 76%

Equity

H.C. Wainwright expressed optimism about the company’s prospects after Celcuity’s breast cancer therapy achieved its primary endpoint in a Phase 3 trial.

Here's Why Biotech ETFs Are Rallying Hard 

Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.

Why Did GLUE Stock Surge Over 50% In Premarket Today?

Monte Rosa Therapeutics reported positive interim Phase 1 data for MRT-8102, showing significant anti-inflammatory effects in patients with elevated cardiovascular risk.

Temas Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance

Tema ETFs (Tema), the New York-based manager of innovative exchange-traded funds (ETFs), is pleased to announce the Tema Oncology ETF (CANC) has surpassed $100m in assets under management (AUM) two...

Be Thankful to These ETFs This Year 

Be thankful for this year's resilient ETFs -- BWET, LITP, PINK and CANC -- which shined despite volatility, tariffs, AI worries and Fed shifts.

AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK

NICE has recommended that Aucatzyl be used as a treatment option for adult patients aged 26 years or older with relapsed or refractory B-cell precursor acute lymphoblastic leukemia, the company said. 

Inside the Recent Strength in Biotech ETFs 

Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.



Tema ETF Trust - Tema Oncology ETF

Neutral Sentiment

Up more than 5%

Flat to up 5%

Flat to down 5%

Down more than 5%

What&#39;s your expected total return for the S&amp;P 500 ($SPY) in Q4? 

Drop your reasoning in the comments.

Current Price	$40.99
Prev Close	$41.30
Open	$41.36
Dividend Yield	N/A
50-Day Moving Average	$42.53
Beta	N/A
Avg. Volume	28,492.65
PE Ratio	N/A

52-Week High	$47.00
52-Week Low	$29.28
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

CANC Fundamentals